Trials / Completed
CompletedNCT01742429
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To test the efficacy of 14 day levofloxacin and bismuth-containing second-line therapy for resistant Helicobacter pylori infection, to compare with the classical quadruple therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proton pump inhibitor | |
| DRUG | Bismuth subsalicylate | |
| DRUG | Metronidazole | antibiotic |
| DRUG | Tetracycline | antibiotic |
| DRUG | Amoxicillin | antibiotic |
| DRUG | Levofloxacin | antibiotic |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-12-05
- Last updated
- 2014-08-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01742429. Inclusion in this directory is not an endorsement.